EXPEDITED REVIEW
Comparison of Coronary Artery Bypass Surgery With Percutaneous Coronary Intervention With Drug-Eluting Stents for Unprotected Left Main Coronary Artery Disease
Michael S. Lee, MD,
Nikhil Kapoor, MD,
Faizi Jamal, MD,
Lawrence Czer, MD,
Joseph Aragon, MD,
James Forrester, MD,
Saibal Kar, MD,
Suhail Dohad, MD,
Robert Kass, MD,
Neal Eigler, MD,
Alfredo Trento, MD,
Prediman K. Shah, MD and
Raj R. Makkar, MD*
Cedars-Sinai Medical Center, University of California, Los Angeles School of Medicine, Los Angeles, California
Manuscript received June 16, 2005;
revised manuscript received August 10, 2005,
accepted September 8, 2005.
* Reprint requests and correspondence: Dr. Raj R. Makkar, Cardiovascular Intervention Center, Cedars-Sinai Medical Center, 8631 West Third Street, Room 415E, Los Angeles, California 90048
(Email: Raj.Makkar{at}cshs.org).
OBJECTIVES: This study evaluated the clinical outcomes of consecutive, selected patients treated with coronary artery bypass graft (CABG) surgery or percutaneous coronary intervention (PCI) with drug-eluting stents (DES) for unprotected left main coronary artery (ULMCA) disease.
BACKGROUND: Although recent data suggest that PCI with DES provides better clinical outcomes compared to bare-metal stenting for ULMCA disease, there is a paucity of data comparing PCI with DES to CABG.
METHODS: Since April 2003, when DES first became available at our institution, 123 patients underwent CABG, and 50 patients underwent PCI with DES for ULMCA disease.
RESULTS: High-risk patients (Parsonnet score >15) comprised 46% of the CABG group and 64% of the PCI group (p = 0.04). The 30-day major adverse cardiac and cerebrovascular event (MACCE) rate for CABG and PCI was 17% and 2% (p < 0.01), respectively. The mean follow-up was 6.7 ± 6.2 months in the CABG group and 5.6 ± 3.9 months in the PCI group (p = 0.26). The estimated MACCE-free survival at six months and one year was 83% and 75% in the CABG group versus 89% and 83% in the PCI group (p = 0.20). By multivariable Cox regression, Parsonnet score, diabetes, and CABG were independent predictors of MACCE.
CONCLUSIONS: Despite a higher percentage of high-risk patients, PCI with DES for ULMCA disease was not associated with an increase in immediate or medium-term complications compared with CABG. Our data suggest that a randomized comparison between the two revascularization strategies for ULMCA may be warranted.
|
Abbreviations and Acronyms
| | ARTS = Arterial Revascularization Therapies Study | | CABG = coronary artery bypass graft | | DES = drug-eluting stent | | MACCE = major adverse cardiac and cerebrovascular event | | PCI = percutaneous coronary intervention | | ULMCA = unprotected left main coronary artery |
|
Related Article
-
Drug-Eluting Stenting for Unprotected Left Main Coronary Artery Disease: Are We Ready to Replace Bypass Surgery?
- Donald S. Baim, Laura Mauri, and Donald C. Cutlip
J. Am. Coll. Cardiol. 2006 47: 878-881.
[Full Text]
[PDF]
This article has been cited by other articles:
|
|
|
|
 
Writing Committee Members, L. D. Hillis, P. K. Smith, J. L. Anderson, J. A. Bittl, C. R. Bridges, J. G. Byrne, J. E. Cigarroa, V. J. DiSesa, L. F. Hiratzka, et al.
2011 ACCF/AHA guideline for coronary artery bypass graft surgery: Executive summary A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.
J. Thorac. Cardiovasc. Surg.,
January 1, 2012;
143(1):
4 - 34.
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. Fajadet and A. Chieffo
Current management of left main coronary artery disease
Eur. Heart J.,
January 1, 2012;
33(1):
36 - 50.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. D. Hillis, P. K. Smith, J. L. Anderson, J. A. Bittl, C. R. Bridges, J. G. Byrne, J. E. Cigarroa, V. J. DiSesa, L. F. Hiratzka, A. M. Hutter Jr, et al.
Special Article: 2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery: Executive Summary: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines
Anesth. Analg.,
January 1, 2012;
114(1):
11 - 45.
[Full Text]
[PDF]
|
|
|
|
|
|
|
G. N. Levine, E. R. Bates, J. C. Blankenship, S. R. Bailey, J. A. Bittl, B. Cercek, C. E. Chambers, S. G. Ellis, R. A. Guyton, S. M. Hollenberg, et al.
2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions
J. Am. Coll. Cardiol.,
December 6, 2011;
58(24):
e44 - e122.
[Full Text]
[PDF]
|
|
|
|
|
|
|
G. N. Levine, E. R. Bates, J. C. Blankenship, S. R. Bailey, J. A. Bittl, B. Cercek, C. E. Chambers, S. G. Ellis, R. A. Guyton, S. M. Hollenberg, et al.
2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention: Executive Summary: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions
J. Am. Coll. Cardiol.,
December 6, 2011;
58(24):
2550 - 2583.
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. D. Hillis, P. K. Smith, J. L. Anderson, J. A. Bittl, C. R. Bridges, J. G. Byrne, J. E. Cigarroa, V. J. DiSesa, L. F. Hiratzka, A. M. Hutter Jr, et al.
2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery: Executive Summary: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines Developed in Collaboration With the American Association for Thoracic Surgery, Society of Cardiovascular Anesthesiologists, and Society of Thoracic Surgeons
J. Am. Coll. Cardiol.,
December 6, 2011;
58(24):
2584 - 2614.
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. D. Hillis, P. K. Smith, J. L. Anderson, J. A. Bittl, C. R. Bridges, J. G. Byrne, J. E. Cigarroa, V. J. DiSesa, L. F. Hiratzka, A. M. Hutter Jr, et al.
2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines Developed in Collaboration With the American Association for Thoracic Surgery, Society of Cardiovascular Anesthesiologists, and Society of Thoracic Surgeons
J. Am. Coll. Cardiol.,
December 6, 2011;
58(24):
e123 - e210.
[Full Text]
[PDF]
|
|
|
|
|
|
|
Writing Committee Members, G. N. Levine, E. R. Bates, J. C. Blankenship, S. R. Bailey, J. A. Bittl, B. Cercek, C. E. Chambers, S. G. Ellis, R. A. Guyton, et al.
2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions
Circulation,
December 6, 2011;
124(23):
e574 - e651.
[Full Text]
[PDF]
|
|
|
|
|
|
|
Writing Committee Members, G. N. Levine, E. R. Bates, J. C. Blankenship, S. R. Bailey, J. A. Bittl, B. Cercek, C. E. Chambers, S. G. Ellis, R. A. Guyton, et al.
2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention: Executive Summary: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions
Circulation,
December 6, 2011;
124(23):
2574 - 2609.
[Full Text]
[PDF]
|
|
|
|
|
|
|
Writing Committee Members, L. D. Hillis, P. K. Smith, J. L. Anderson, J. A. Bittl, C. R. Bridges, J. G. Byrne, J. E. Cigarroa, V. J. DiSesa, L. F. Hiratzka, et al.
2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines
Circulation,
December 6, 2011;
124(23):
e652 - e735.
[Full Text]
[PDF]
|
|
|
|
|
|
|
Writing Committee Members, L. D. Hillis, P. K. Smith, J. L. Anderson, J. A. Bittl, C. R. Bridges, J. G. Byrne, J. E. Cigarroa, V. J. DiSesa, L. F. Hiratzka, et al.
2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery: Executive Summary: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines
Circulation,
December 6, 2011;
124(23):
2610 - 2642.
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. E. Halkos, S. T. Rab, T. A. Vassiliades, D. C. Morris, J. S. Douglas, P. D. Kilgo, H. A. Liberman, R. A. Guyton, V. H. Thourani, and J. D. Puskas
Hybrid Coronary Revascularization Versus Off-Pump Coronary Artery Bypass for the Treatment of Left Main Coronary Stenosis
Ann. Thorac. Surg.,
December 1, 2011;
92(6):
2155 - 2160.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. P. Kappetein, T. E. Feldman, M. J. Mack, M.-C. Morice, D. R. Holmes, E. Stahle, K. D. Dawkins, F. W. Mohr, P. W. Serruys, and A. Colombo
Comparison of coronary bypass surgery with drug-eluting stenting for the treatment of left main and/or three-vessel disease: 3-year follow-up of the SYNTAX trial
Eur. Heart J.,
September 1, 2011;
32(17):
2125 - 2134.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
E. J. McNulty, W. Ng, J. A. Spertus, J. G. Zaroff, R. W. Yeh, X. M. Ren, and R. J. Lundstrom
Surgical Candidacy and Selection Biases in Nonemergent Left Main Stenting: Implications for Observational Studies
J. Am. Coll. Cardiol. Intv.,
September 1, 2011;
4(9):
1020 - 1027.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J.-Y. Lee, D.-W. Park, Y.-H. Kim, S.-C. Yun, W.-J. Kim, S.-J. Kang, S.-W. Lee, C.-W. Lee, S.-W. Park, and S.-J. Park
Incidence, Predictors, Treatment, and Long-Term Prognosis of Patients With Restenosis After Drug-Eluting Stent Implantation for Unprotected Left Main Coronary Artery Disease
J. Am. Coll. Cardiol.,
March 22, 2011;
57(12):
1349 - 1358.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
E. Boudriot, H. Thiele, T. Walther, C. Liebetrau, P. Boeckstegers, T. Pohl, B. Reichart, H. Mudra, F. Beier, B. Gansera, et al.
Randomized Comparison of Percutaneous Coronary Intervention With Sirolimus-Eluting Stents Versus Coronary Artery Bypass Grafting in Unprotected Left Main Stem Stenosis
J. Am. Coll. Cardiol.,
February 1, 2011;
57(5):
538 - 545.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D.-W. Park, Y.-H. Kim, S.-C. Yun, J.-Y. Lee, W.-J. Kim, S.-J. Kang, S.-W. Lee, C.-W. Lee, J.-J. Kim, S.-J. Choo, et al.
Long-Term Outcomes After Stenting Versus Coronary Artery Bypass Grafting for Unprotected Left Main Coronary Artery Disease: 10-Year Results of Bare-Metal Stents and 5-Year Results of Drug-Eluting Stents From the ASAN-MAIN (ASAN Medical Center-Left MAIN Revascularization) Registry
J. Am. Coll. Cardiol.,
October 19, 2010;
56(17):
1366 - 1375.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. Chikwe, M. Kim, A. B. Goldstone, A. Fallahi, and T. Athanasiou
Current diagnosis and management of left main coronary disease
Eur J Cardiothorac Surg,
October 1, 2010;
38(4):
420 - 430.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D.-W. Park, K. B. Seung, Y.-H. Kim, J.-Y. Lee, W.-J. Kim, S.-J. Kang, S.-W. Lee, C. W. Lee, S.-W. Park, S.-C. Yun, et al.
Long-Term Safety and Efficacy of Stenting Versus Coronary Artery Bypass Grafting for Unprotected Left Main Coronary Artery Disease: 5-Year Results From the MAIN-COMPARE (Revascularization for Unprotected Left Main Coronary Artery Stenosis: Comparison of Percutaneous Coronary Angioplasty Versus Surgical Revascularization) Registry
J. Am. Coll. Cardiol.,
July 6, 2010;
56(2):
117 - 124.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M.-C. Morice, P. W. Serruys, A. P. Kappetein, T. E. Feldman, E. Stahle, A. Colombo, M. J. Mack, D. R. Holmes, L. Torracca, G.-A. van Es, et al.
Outcomes in Patients With De Novo Left Main Disease Treated With Either Percutaneous Coronary Intervention Using Paclitaxel-Eluting Stents or Coronary Artery Bypass Graft Treatment in the Synergy Between Percutaneous Coronary Intervention With TAXUS and Cardiac Surgery (SYNTAX) Trial
Circulation,
June 22, 2010;
121(24):
2645 - 2653.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Y.-H. Kim, D.-W. Park, W.-J. Kim, J.-Y. Lee, S.-C. Yun, S.-J. Kang, S.-W. Lee, C. W. Lee, M.-K. Hong, S.-W. Park, et al.
Impact of the Extent of Coronary Artery Disease on Outcomes After Revascularization for Unprotected Left Main Coronary Artery Stenosis
J. Am. Coll. Cardiol.,
June 8, 2010;
55(23):
2544 - 2552.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Chieffo, V. Magni, A. Latib, F. Maisano, A. Ielasi, M. Montorfano, M. Carlino, C. Godino, M. Ferraro, G. Calori, et al.
5-Year Outcomes Following Percutaneous Coronary Intervention With Drug-Eluting Stent Implantation Versus Coronary Artery Bypass Graft for Unprotected Left Main Coronary Artery Lesions: The Milan Experience
J. Am. Coll. Cardiol. Intv.,
June 1, 2010;
3(6):
595 - 601.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Y.-H. Kim, D.-W. Park, W.-J. Kim, J.-Y. Lee, S.-C. Yun, S.-J. Kang, S.-W. Lee, C. W. Lee, S.-W. Park, and S.-J. Park
Validation of SYNTAX (Synergy between PCI with Taxus and Cardiac Surgery) Score for Prediction of Outcomes After Unprotected Left Main Coronary Revascularization
J. Am. Coll. Cardiol. Intv.,
June 1, 2010;
3(6):
612 - 623.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Y. Min, D. W. Park, S. C. Yun, Y. H. Kim, J. Y. Lee, S. J. Kang, S. W. Lee, C. W. Lee, J. J. Kim, S. W. Park, et al.
Major Predictors of Long-Term Clinical Outcomes After Coronary Revascularization in Patients With Unprotected Left Main Coronary Disease: Analysis From the MAIN-COMPARE Study
Circ Cardiovasc Interv,
April 1, 2010;
3(2):
127 - 133.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. Hughes, B. Farah, and J. Fajadet
Chapter 19 Percutaneous coronary intervention for unprotected and protected left main stem disease
Oxford Textbook of Interventional Cardiology,
January 1, 2010;
1(1):
med-9780199569083-chapter - med-9780199569083-chapter.
[Abstract]
[Full Text]
|
|
|
|
|
|
|
F. G. Kushner, M. Hand, S. C. Smith Jr, S. B. King III, J. L. Anderson, E. M. Antman, S. R. Bailey, E. R. Bates, J. C. Blankenship, D. E. Casey Jr, et al.
2009 Focused Updates: ACC/AHA Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction (Updating the 2004 Guideline and 2007 Focused Update) and ACC/AHA/SCAI Guidelines on Percutaneous Coronary Intervention (Updating the 2005 Guideline and 2007 Focused Update): A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines
J. Am. Coll. Cardiol.,
December 1, 2009;
54(23):
2205 - 2241.
[Full Text]
[PDF]
|
|
|
|
|
|
|
F. G. Kushner, M. Hand, S. C. Smith Jr, S. B. King III, J. L. Anderson, E. M. Antman, S. R. Bailey, E. R. Bates, J. C. Blankenship, D. E. Casey Jr, et al.
2009 Focused Updates: ACC/AHA Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction (Updating the 2004 Guideline and 2007 Focused Update) and ACC/AHA/SCAI Guidelines on Percutaneous Coronary Intervention (Updating the 2005 Guideline and 2007 Focused Update): A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines
Circulation,
December 1, 2009;
120(22):
2271 - 2306.
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. E. Kandzari, A. Colombo, S.-J. Park, C. L. Tommaso, S. G. Ellis, L. A. Guzman, P. S. Teirstein, C. Tamburino, J. Ormiston, G. W. Stone, et al.
Revascularization for Unprotected Left Main Disease: Evolution of the Evidence Basis to Redefine Treatment Standards
J. Am. Coll. Cardiol.,
October 20, 2009;
54(17):
1576 - 1588.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
G. Montalescot, D. Brieger, K. A. Eagle, F. A. Anderson Jr, G. FitzGerald, M. S. Lee, Ph. G. Steg, A. Avezum, S. G. Goodman, J. M. Gore, et al.
Unprotected left main revascularization in patients with acute coronary syndromes
Eur. Heart J.,
October 1, 2009;
30(19):
2308 - 2317.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Y. H. Kim, D. W. Park, S. W. Lee, S. C. Yun, C. W. Lee, M. K. Hong, S. W. Park, K. B. Seung, H. C. Gwon, M. H. Jeong, et al.
Long-Term Safety and Effectiveness of Unprotected Left Main Coronary Stenting With Drug-Eluting Stents Compared With Bare-Metal Stents
Circulation,
August 4, 2009;
120(5):
400 - 407.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
H. Naik, A. J. White, T. Chakravarty, J. Forrester, G. Fontana, S. Kar, P. K. Shah, R. E. Weiss, and R. Makkar
A Meta-Analysis of 3,773 Patients Treated With Percutaneous Coronary Intervention or Surgery for Unprotected Left Main Coronary Artery Stenosis
J. Am. Coll. Cardiol. Intv.,
August 1, 2009;
2(8):
739 - 747.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
O. Soran, A. Manchanda, and S. Schueler
Percutaneous coronary intervention versus coronary artery bypass surgery in multivessel disease: a current perspective
Interact CardioVasc Thorac Surg,
June 1, 2009;
8(6):
666 - 671.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S.-J. Park, Y.-H. Kim, D.-W. Park, S.-W. Lee, W.-J. Kim, J. Suh, S.-C. Yun, C. W. Lee, M.-K. Hong, J.-H. Lee, et al.
Impact of Intravascular Ultrasound Guidance on Long-Term Mortality in Stenting for Unprotected Left Main Coronary Artery Stenosis
Circ Cardiovasc Interv,
June 1, 2009;
2(3):
167 - 177.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. Tamburino, M. E. Di Salvo, D. Capodanno, A. Marzocchi, I. Sheiban, M. Margheri, A. Maresta, F. Barlocco, G. Sangiorgi, G. Piovaccari, et al.
Are drug-eluting stents superior to bare-metal stents in patients with unprotected non-bifurcational left main disease? Insights from a multicentre registry
Eur. Heart J.,
May 2, 2009;
30(10):
1171 - 1179.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
T. Palmerini, A. Marzocchi, C. Tamburino, I. Sheiban, M. Margheri, G. Vecchi, G. Sangiorgi, A. Santarelli, A. L. Bartorelli, C. Briguori, et al.
Temporal Pattern of Ischemic Events in Relation to Dual Antiplatelet Therapy in Patients With Unprotected Left Main Coronary Artery Stenosis Undergoing Percutaneous Coronary Intervention
J. Am. Coll. Cardiol.,
April 7, 2009;
53(14):
1176 - 1181.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. R. Smith
Surgery, Not Percutaneous Revascularization, Is the Preferred Strategy for Patients With Significant Left Main Coronary Stenosis
Circulation,
February 24, 2009;
119(7):
1013 - 1020.
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. S. Teirstein
Percutaneous Revascularization Is the Preferred Strategy for Patients With Significant Left Main Coronary Stenosis
Circulation,
February 24, 2009;
119(7):
1021 - 1033.
[Full Text]
[PDF]
|
|
|
|
|
|
|
S.-J. Park and D.-W. Park
Percutaneous Coronary Intervention With Stent Implantation Versus Coronary Artery Bypass Surgery for Treatment of Left Main Coronary Artery Disease: Is It Time to Change Guidelines?
Circ Cardiovasc Interv,
February 1, 2009;
2(1):
59 - 68.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
H. Takagi, N. Kawai, and T. Umemoto
Stenting versus coronary artery bypass grafting for unprotected left main coronary artery disease: a meta-analysis of comparative studies.
J. Thorac. Cardiovasc. Surg.,
January 1, 2009;
137(1):
e54 - e57.
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. Rodes-Cabau, J. DeBlois, O. F. Bertrand, S. Mohammadi, J. Courtis, E. Larose, F. Dagenais, J.-P. Dery, P. Mathieu, M. Rousseau, et al.
Nonrandomized Comparison of Coronary Artery Bypass Surgery and Percutaneous Coronary Intervention for the Treatment of Unprotected Left Main Coronary Artery Disease in Octogenarians
Circulation,
December 2, 2008;
118(23):
2374 - 2381.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
T. Palmerini, A. Marzocchi, C. Tamburino, I. Sheiban, M. Margheri, G. Vecchi, G. Sangiorgi, A. Santarelli, A. Bartorelli, C. Briguori, et al.
Impact of Bifurcation Technique on 2-Year Clinical Outcomes in 773 Patients With Distal Unprotected Left Main Coronary Artery Stenosis Treated With Drug-Eluting Stents
Circ Cardiovasc Interv,
December 1, 2008;
1(3):
185 - 192.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
E. Meliga, A. O. Maree, H. M. Garcia-Garcia, and P. W. Serruys
Reply
J. Am. Coll. Cardiol.,
November 11, 2008;
52(20):
1681 - 1681.
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. Wu, E. L. Hannan, G. Walford, and D. P. Faxon
Utilization and Outcomes of Unprotected Left Main Coronary Artery Stenting and Coronary Artery Bypass Graft Surgery
Ann. Thorac. Surg.,
October 1, 2008;
86(4):
1153 - 1159.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Chieffo, S.-J. Park, E. Meliga, I. Sheiban, M. S. Lee, A. Latib, Y.-H. Kim, M. Valgimigli, D. Sillano, V. Magni, et al.
Late and very late stent thrombosis following drug-eluting stent implantation in unprotected left main coronary artery: a multicentre registry
Eur. Heart J.,
September 1, 2008;
29(17):
2108 - 2115.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
E. Meliga, M. Valgimigli, P. Buszman, and P. W. Serruys
Percutaneous Coronary Intervention or Coronary Artery Bypass Graft for Unprotected Left Main Coronary Artery Disease: The Endless Debate
J. Am. Coll. Cardiol.,
August 12, 2008;
52(7):
582 - 584.
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. S. Brar, G. Syros, and G. Dangas
Multivessel Disease: Percutaneous Coronary Intervention for Classic Coronary Artery Bypass Grafting Indications
Angiology,
August 1, 2008;
59(2_suppl):
83S - 88S.
[Abstract]
[PDF]
|
|
|
|
|
|
|
M. S. Lee, C.-H. Tseng, C. M. Barker, V. Menon, D. Steckman, R. Shemin, and J. S. Hochman
Outcome After Surgery and Percutaneous Intervention for Cardiogenic Shock and Left Main Disease
Ann. Thorac. Surg.,
July 1, 2008;
86(1):
29 - 34.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
E. Meliga, H. M. Garcia-Garcia, M. Valgimigli, A. Chieffo, G. Biondi-Zoccai, A. O. Maree, S. Cook, L. Reardon, C. Moretti, S. De Servi, et al.
Longest Available Clinical Outcomes After Drug-Eluting Stent Implantation for Unprotected Left Main Coronary Artery Disease: The DELFT (Drug Eluting stent for LeFT main) Registry
J. Am. Coll. Cardiol.,
June 10, 2008;
51(23):
2212 - 2219.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. J. White, G. Kedia, J. M. Mirocha, M. S. Lee, J. S. Forrester, W. C. Morales, S. Dohad, S. Kar, L. S. Czer, G. P. Fontana, et al.
Comparison of Coronary Artery Bypass Surgery and Percutaneous Drug-Eluting Stent Implantation for Treatment of Left Main Coronary Artery Stenosis
J. Am. Coll. Cardiol. Intv.,
June 1, 2008;
1(3):
236 - 245.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. G. Malvindi, J. Dunning, and N. Vitale
For which patients with left main stem disease is percutaneous intervention rather than coronary artery bypass grafting the better option?
Interact CardioVasc Thorac Surg,
April 1, 2008;
7(2):
306 - 314.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. P. Taggart, S. Kaul, W. E. Boden, T. B. Ferguson Jr, R. A. Guyton, M. J. Mack, P. T. Sergeant, R. J. Shemin, P. K. Smith, and S. Yusuf
Revascularization for Unprotected Left Main Stem Coronary Artery Stenosis: Stenting or Surgery
J. Am. Coll. Cardiol.,
March 4, 2008;
51(9):
885 - 892.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. Brinker
The Left Main Facts: Faced, Spun, But Alas Too Few
J. Am. Coll. Cardiol.,
March 4, 2008;
51(9):
893 - 898.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. E. Buszman, S. R. Kiesz, A. Bochenek, E. Peszek-Przybyla, I. Szkrobka, M. Debinski, B. Bialkowska, D. Dudek, A. Gruszka, A. Zurakowski, et al.
Acute and Late Outcomes of Unprotected Left Main Stenting in Comparison With Surgical Revascularization
J. Am. Coll. Cardiol.,
February 5, 2008;
51(5):
538 - 545.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. S. Teirstein
Unprotected left main intervention patient selection, operator technique, and clinical outcomes.
J. Am. Coll. Cardiol. Intv.,
February 1, 2008;
1(1):
5 - 13.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
T. Palmerini, F. Barlocco, A. Santarelli, L. Bacchi-Reggiani, C. Savini, E. Baldini, L. Alessi, M. Ruffini, G. Di Credico, G. Piovaccari, et al.
A comparison between coronary artery bypass grafting surgery and drug eluting stent for the treatment of unprotected left main coronary artery disease in elderly patients (aged >=75 years)
Eur. Heart J.,
November 2, 2007;
28(22):
2714 - 2719.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. A Khattab, C. W Hamm, J. Senges, R. Toelg, V. Geist, T. Bonzel, M. Kelm, B. Levenson, F.-J. Neumann, C. A Nienaber, et al.
Sirolimus-eluting stent treatment for unprotected versus protected left main coronary artery disease in widespread clinical routine: 6-month and 3-year clinical follow-up results from the prospective multicentre German Cypher Registry
Heart,
October 1, 2007;
93(10):
1251 - 1255.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Kanemitsu, K. Tanaka, J. Tanaka, H. Suzuki, and T. Kinoshita
Initial clinical impact of drug eluting stents on coronary artery bypass graft surgery
Interact CardioVasc Thorac Surg,
October 1, 2007;
6(5):
632 - 635.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Colombo and A. Chieffo
Drug-Eluting Stent Update 2007: Part III: Technique and Unapproved/Unsettled Indications (Left Main, Bifurcations, Chronic Total Occlusions, Small Vessels and Long Lesions, Saphenous Vein Grafts, Acute Myocardial Infarctions, and Multivessel Disease)
Circulation,
September 18, 2007;
116(12):
1424 - 1432.
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. F. Sabik III, E. H. Blackstone, M. Firstenberg, and B. W. Lytle
A Benchmark for Evaluating Innovative Treatment of Left Main Coronary Disease
Circulation,
September 11, 2007;
116(11_suppl):
I-232 - I-239.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
G. W. Stone, J. W. Moses, and M. B. Leon
Left Main Drug-Eluting Stents: Natural Progression or a Bridge Too Far?
J. Am. Coll. Cardiol.,
August 7, 2007;
50(6):
498 - 500.
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. R. Dixon, C. L. Grines, and W. W. O'Neill
The Year in Interventional Cardiology
J. Am. Coll. Cardiol.,
July 17, 2007;
50(3):
270 - 285.
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Chieffo, S. J. Park, M. Valgimigli, Y. H. Kim, J. Daemen, I. Sheiban, A. Truffa, M. Montorfano, F. Airoldi, G. Sangiorgi, et al.
Favorable Long-Term Outcome After Drug-Eluting Stent Implantation in Nonbifurcation Lesions That Involve Unprotected Left Main Coronary Artery: A Multicenter Registry
Circulation,
July 10, 2007;
116(2):
158 - 162.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. N. DeMaria, O. Ben-Yehuda, G. K. Feld, G. S. Ginsburg, B. H. Greenberg, W. Y.W. Lew, J. A.C. Lima, A. S. Maisel, J. Narula, D. J. Sahn, et al.
Highlights of the Year in JACC 2006
J. Am. Coll. Cardiol.,
January 30, 2007;
49(4):
509 - 527.
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. Kimmelstiel
Multislice Computed Tomography After Left Main Drug-Eluting Stenting: Are We Putting the CarT Before the Horse?
Circulation,
August 15, 2006;
114(7):
616 - 619.
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. J. Kereiakes and D. P. Faxon
Left Main Coronary Revascularization at the Crossroads
Circulation,
May 30, 2006;
113(21):
2480 - 2484.
[Full Text]
[PDF]
|
|
|
|
|
|
|
Unprotected LMCA Stenting: Further Insights
Journal Watch Cardiology,
April 6, 2006;
2006(406):
4 - 4.
[Full Text]
|
|
|
|
|
|
|
D. S. Baim, L. Mauri, and D. C. Cutlip
Drug-Eluting Stenting for Unprotected Left Main Coronary Artery Disease: Are We Ready to Replace Bypass Surgery?
J. Am. Coll. Cardiol.,
February 21, 2006;
47(4):
878 - 881.
[Full Text]
[PDF]
|
|
|
|
